Global biopharma companies are increasingly using RWE to strengthen regulatory submissions. Aetion’s new eBook is designed to help inform your RWE strategy, guiding you through when, where, and how RWE studies have supported FDA approvals for new drugs and biologics. In addition, learn from deep dives into two external control arms submitted to support FDA approvals—one which provided substantial evidence and one with design limitations—and see how you can apply the takeaways to generate high-quality RWE studies. Download the e-book here.
You are here: / / [Ebook] The Role of Real-world Evidence in FDA Approvals